Iradimed Valuation
| IRMD Stock | USD 52.75 0.83 1.55% |
At this time, the firm appears to be undervalued. Iradimed retains a regular Real Value of $54.96 per share. The prevalent price of the firm is $52.75. Our model calculates the value of Iradimed from evaluating the firm fundamentals such as Return On Equity of 0.24, return on asset of 0.15, and Current Valuation of 627.59 M as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Iradimed's valuation include:
Price Book 8.1388 | Enterprise Value 627.6 M | Enterprise Value Ebitda 28.3302 | Price Sales 9.523 | Forward PE 31.1526 |
Undervalued
Today
Please note that Iradimed's price fluctuation is very steady at this time. Calculation of the real value of Iradimed is based on 3 months time horizon. Increasing Iradimed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Iradimed stock is determined by what a typical buyer is willing to pay for full or partial control of Iradimed Co. Since Iradimed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Iradimed Stock. However, Iradimed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 52.75 | Real 54.96 | Target 58.33 | Hype 51.62 |
The real value of Iradimed Stock, also known as its intrinsic value, is the underlying worth of Iradimed Company, which is reflected in its stock price. It is based on Iradimed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Iradimed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Iradimed Co helps investors to forecast how Iradimed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Iradimed more accurately as focusing exclusively on Iradimed's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Iradimed's intrinsic value based on its ongoing forecasts of Iradimed's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Iradimed's closest peers. If more than one evaluation category is relevant for Iradimed we suggest using both methods to arrive at a better estimate.
Iradimed Cash |
|
Iradimed Valuation Trend
Comparing Iradimed's enterprise value against its market capitalization is a good way to estimate the value of Iradimed Co uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Iradimed Total Value Analysis
Iradimed Co is currently expected to have valuation of 627.59 M with market capitalization of 679.04 M, debt of 2.04 M, and cash on hands of 55.59 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Iradimed fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
627.59 M | 679.04 M | 2.04 M | 55.59 M |
Iradimed Investor Information
About 37.0% of the company shares are held by company insiders. The company last dividend was issued on the 15th of November 2024. Based on the measurements of operating efficiency obtained from Iradimed's historical financial statements, Iradimed Co may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 7.7 M | 13.5 M |
|
|
Iradimed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Iradimed has an asset utilization ratio of 71.14 percent. This indicates that the Company is making $0.71 for each dollar of assets. An increasing asset utilization means that Iradimed Co is more efficient with each dollar of assets it utilizes for everyday operations.Iradimed Ownership Allocation
Over half of Iradimed's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions.Iradimed Profitability Analysis
The company reported the previous year's revenue of 65.56 M. Net Income was 17.19 M with profit before overhead, payroll, taxes, and interest of 41.28 M.Iradimed Past Distributions to stockholders
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Iradimed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Iradimed and how it compares across the competition.
About Iradimed Valuation
The stock valuation mechanism determines Iradimed's current worth on a weekly basis. Our valuation model uses a comparative analysis of Iradimed. We calculate exposure to Iradimed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Iradimed's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 50.2 M | 27.1 M | |
| Pretax Profit Margin | 0.33 | 0.18 | |
| Operating Profit Margin | 0.31 | 0.24 | |
| Net Profit Margin | 0.26 | 0.14 | |
| Gross Profit Margin | 0.77 | 0.62 |
Iradimed Quarterly Retained Earnings |
|
A single share of Iradimed represents a small ownership stake in the entity. As a stockholder of Iradimed, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Iradimed Dividends Analysis For Valuation
At present, Iradimed's Dividend Payout Ratio is projected to slightly decrease based on the last few years of reporting. . The current year's Price Earnings To Growth Ratio is expected to grow to 1.10, whereas Retained Earnings are forecasted to decline to about 27.5 M.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 13.2 M | 7.8 M | |
| Dividend Yield | 0.02 | 0.03 | |
| Dividend Payout Ratio | 0.77 | 0.96 | |
| Dividend Paid And Capex Coverage Ratio | 0.63 | 0.60 |
There are various types of dividends Iradimed can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Iradimed shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Iradimed Co directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Iradimed pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Iradimed by the value of the dividends paid out.
Iradimed Growth Indicators
Investing in growth stocks can be very risky. If the company such as Iradimed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 12.7 M | |
| Quarterly Earnings Growth Y O Y | -0.004 | |
| Forward Price Earnings | 31.1526 |
Iradimed Current Valuation Indicators
Valuation refers to the process of determining the present value of Iradimed Co and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Iradimed we look at many different elements of the entity such as Iradimed's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Iradimed, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Iradimed's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Iradimed's worth.Complementary Tools for Iradimed Stock analysis
When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |